ARK Genomic Revolution fund starts position in Burning Rock Biotech

0
133

The ARK Genomic Revolution ETF ARKG, +2.01% started a position in Burning Rock Biotech BNR, +10.69%, a Chinese cancer sequencing technology company that jumped 11% after reporting third-quarter results. The loss-making biotech saw its revenue edge up 2% in the third quarter and is planning two products for early-stage cancer patients next year. In other moves, two Ark funds sold nearly $23 million worth of Unity Software U, -0.78%, while the ARK Next Generation Internet ETF continued to boost its holding in Robinhood Markets HOOD, -3.12%.

This article was originally published by Marketwatch.com. Read the original article here.

Previous articleMark Hulbert: Stocks, gold, TIPS and these specialized ETFs all fight inflation. Here’s what you need to know about them.
Next articlePound rises after U.K. CPI climbs stronger-than-forecast 4.2% YOY in October

LEAVE A REPLY

Please enter your comment!
Please enter your name here